Journal of Natural Products
ARTICLE
Hamoh moiety had been replaced by resonances for a carbinol
moiety (δH 3.28 and δC 71.5). This, together with the molecular
weight difference of 2 between 4 and 3, suggested that the ketone
in Hamoh of 3 had been reduced to a hydroxy group in 4, forming
a Hamhh residue (2-hydroxy-3-amino-4-methyl-14-hydroxyhex-
adecanoic acid). The structure of Hamhh was further supported
by analysis of the COSY and HMBC spectra. Sequential COSY
correlations between H3-16 (δH 0.83)/H2-15 (δH 1.16 and
1.35)/H-14 (δH 3.28) and an HMBC correlation from H3-16
(δH 0.83) to C-14 (δC 71.5) placed the hydroxy group at C-14.
The absolute configurations of the amino acid residues and the
three asymmetric centers in the Hamhh residue appeared to be
the same as those found for 1 by comparison of 13C chemical
shifts and specific rotation ([R]D +2). Compound 4 possessed
one more stereogenic hydroxy-bearing carbinol carbon (C-14) in
the Hamhh residue. Mosher’s ester analysis was attempted in an
effort to assign the absolute configuration of this carbinol center.
However, the presence of three hydroxy groups (one in Thr and
two in Hamhh) resulted in a mixture of products and a very
complex 1H NMR spectrum of the Mosher’s ester products of 4.
Hydrolysis of 4 followed by isolation of the Hamhh residue
would be necessary for Mosher’s ester analysis, but was not
attempted due to the limited amount of sample available. Thus,
the absolute configuration of the C-13 carbinol carbon in Hamhh
could not be assigned conclusively.
The structures of minutissamides AꢀD (1ꢀ4) were charac-
terized by the presence of a β-amino acid residue, a 2-hydroxy-3-
amino-4-methyldodecanoic or -hexadecanoic acid, and three
nonstandard amino acid residues (NMeAsn and two Dhbs).
The β-amino acid residues were further modified by chlorination
in 2, by oxidation to ketone in 3, or by hydroxylation in 4. Inter-
estingly, the structures of minutissamides AꢀD (1ꢀ4) revealed
some similarities to the cyclic decapeptides puwainaphycins AꢀE,
isolated from a Hawaiian terrestrial Anabaena sp.9 The sequence
of the five residues in the puwainaphycins, including Dhb, Val,
β-amino acid unit, Pro, and NMeAsn, was conserved in the
minutissamides. The other five amino acid residues, OMT
(O-methyl-Thr), Gly, Gln, Thr-2 (or Val-2), and Thr-1, found
in the puwainaphycins were replaced by Thr, Ala, Asn1, Dhb1,
and Asn2 in the minutissamides. The core structure of the
lipophilic β-amino acid residues, characterized by 2-hydroxy-3-
amino-4-methyl substitution, and the chlorination and oxidation
patterns were also similar to those observed in the puwainaphycins.
Minutissamides AꢀD (1ꢀ4) were evaluated for their anti-
proliferative activity against the HT-29 human colon cancer cell
line. Minutissamide A (1) displayed antiproliferative activity with
an IC50 value of 2.0 μM, whereas lower activity was observed for
minutissamides BꢀD (2ꢀ4) with IC50 values of 20.0, 11.8, and
22.7 μM, respectively. All four minutissamides have identical
cyclic peptide cores and only differ in the lipophilic β-amino acid
residue. For example, the only structural difference between
minutissamides A (1) and B (2) was the presence of a chlorine
atom at C-12 of this residue, but minutissamide A (1) was found
to be 10-fold more active in the HT-29 assay. This suggests that
the β-amino acid residue plays an important role in the anti-
proliferative activity of these compounds.
190 to 360 nm. 1D and 2D NMR spectra were obtained on a Bruker
Avance DRX 600 MHz NMR spectrometer with a 5 mm CPTXI
Z-gradient probe and a Bruker Avance II 900 MHz NMR spectrometer
with a 5 mm ATM CPTCI Z-gradient probe. 1H and 13C NMR chemical
shifts were referenced to the DMSO-d6 solvent signals (δH 2.50 and δC
39.51, respectively). A mixing time of 60 ms was set for the TOCSY
experiments and 200 ms for the T-ROESY experiment. The HMBC
spectra were recorded with the 3JCꢀH set to 8 Hz, and the HSQC spectra
were collected with the 1JCꢀH set to 140 Hz. High-resolution ESI mass
spectra were obtained using a Shimadzu IT-TOF LC mass spectrometer.
Tandem mass analysis was performed using a Micromass Q-TOF LC
mass spectrometer.
Biological Material. Anabaena minutissima was acquired from the
Culture Collection of Algae at the University of Texas at Austin (UTEX
1613). The cyanobacterium was grown in 20 L flasks containing 18 L of
inorganic media (Z media).13 Cultures were illuminated with fluores-
cent lamps at 1.03 klx. The temperature of the culture room was
maintained at 22 °C. After 6ꢀ8 weeks, the biomass of cyanobacteria
was harvested by centrifugation and then freeze-dried.
Extraction and Isolation. The freeze-dried biomass (5.2 g) from
the total 54 L (3 ꢁ 18 L) culture was harvested and extracted with
CH2Cl2ꢀMeOH (1:1) and concentrated in vacuo to yield 1.1 g of the
extract. The extract was fractionated using Diaion HP-20 with increasing
amounts of IPA in H2O to generate eight subfractions (0, 20, 40, 60, 70,
80, 90, 100% aqueous IPA). Fraction 3 (40% IPA) indicated the pres-
ence of four peptides by LC-MS. This fraction was further purified by
Sephadex LH-20 column chromatography in MeOH. Fractions 7ꢀ9
containing the peptides were subjected to reversed-phased HPLC
(Varian C8 semipreparative column, 10 mm ꢁ 250 mm, 3 mL/min)
eluting with a linear gradient from 60 to 80% aqueous MeOH for 45 min.
Minutissamaides AꢀD (1ꢀ4) were eluted at 37.9 min (1, 1.4 mg), 31.6 min
(2, 0.4 mg), 30.0 min (3, 1.0 mg), and 33.5 min (4, 0.7 mg), respectively.
Minutissamide A (1): colorless, amorphous powder; [R]25 +4
D
(c 0.06, MeOH); UV (MeOH) λmax (log ε) 243 (3.45) nm; IR (neat)
3317 (br), 2925, 2861, 1681, 1635 (br), 1561, 1541 cmꢀ1; 1H and 13
C
NMR (see Table 1); HRESIMS m/z 1140.6049 [M + Na]+ (calcd for
C51H83N13O15Na, 1140.6029).
Minutissamide B (2): colorless, amorphous powder; [R]25 +5
D
(c 0.02, MeOH); UV (MeOH) λmax (log ε) 230 (4.24) nm; IR (neat)
3315 (br), 2926, 2852, 1670, 1647 (br), 1545, 1516, 1459, 1402 cmꢀ1
;
1H and 13C NMR (see Table 1); HRESIMS m/z 1174.5680 [M + Na]+
(calcd for C51H83ClN13O15Na, 1174.5640).
Minutissamide C (3): colorless, amorphous powder; [R]25 +3
D
(c 0.07, MeOH); UV (MeOH) λmax (log ε) 242 (2.62) nm; IR (neat)
3315 (br), 2926, 2857, 1664, 1630 (br), 1533, 1447, 1402 cmꢀ1; 1H and
13C NMR (see Table 2); HRESIMS m/z 1210.6440 [M + Na]+ (calcd
for C55H89N13O16Na, 1210.6448).
Minutissamide D (4): colorless, amorphous powder; [R]25 +2
D
(c 0.05, MeOH); UV (MeOH) λmax (log ε) 240 (3.94) nm; IR (neat)
3320 (br), 2926, 2852, 1664, 1636 (br), 1539, 1453, 1379 cmꢀ1; 1H and
13C NMR (see Table 2); HRESIMS m/z 1212.6632 [M + Na]+ (calcd
for C55H91N13O16Na, 1212.6604).
Determination of Amino Acid Configurations. Approxi-
mately 0.3 mg of minutissamide A was hydrolyzed using 6 N HCl
(500 μL) in a high-pressure tube for 16 h at 110 °C. The hydrolysate was
dried under vacuum and redissolved in H2O. This procedure was
repeated three times to completely remove the remaining HCl. For
the derivatization with Marfey’s reagent (FDAA), the hydrolysate (0.1
mg) or amino acid standard was dissolved in 50 μL of H2O, and 20 μL of
1 N NaHCO3 and 110 μL of acetone were added. The reaction was
initiated by adding 20 μL of FDAA solution (10 mg/mL w/v in
acetone), proceeded for 1 h at 40 °C, and was quenched by adding 20
μL of 1 N HCl. The reactant was dried under vacuum and redissolved in
CH3CN for HPLC analysis. Chromatographic analysis of the FDAA
’ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were
measured using a Perkin-Elmer 241 polarimeter. UV spectra were
recorded on a Shimadzu UV spectrometer UV2401 and scanned from
1604
dx.doi.org/10.1021/np2002226 |J. Nat. Prod. 2011, 74, 1597–1605